Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team

Enorama Pharma

2.59

 

SEK

 

-3.72 %

Less than 1K followers

ERMA

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Ownership
Investor consensus
Compare
-3.72%
-3.36%
+15.11%
-22.92%
-25.14%
+7.92%
-77.57%
-91.95%
-59.33%

Enorama Pharma is a pharmaceutical company. The company's operations are focused on producing and developing medical nicotine chewing gum. The products are mainly sold through retailers who sell the product under their own brand. The largest market is established in the Nordic region, but also worldwide. Enorama Pharma was founded in 2006 and the head office is located in Malmö.

Read more
Market cap
173.89M SEK
Turnover
30.26K SEK
Revenue
15.77M
EBIT %
-301.33 %
P/E
-
Dividend yield-%
-
Financial calendar
20.8
2025

Interim report Q2'25

19.11
2025

Interim report Q3'25

18.2
2026

Annual report '25

All
Press releases
ShowingAll content types
Regulatory press release9/25/2024, 10:00 AM

Enorama Pharma AB (publ) Explores Divestment of Nicotine Replacement Therapy Chewing Gum Business

Enorama Pharma

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team